Fibroblast Growth Factor-2 Antagonist and Antiangiogenic Activity of Long-Pentraxin 3-Derived Synthetic Peptides

By  

Current Pharmaceutical Design, Vol. 15, Iss. 30, 2009-10 ,pp. : 3577-3589

Bentham Science Publishers

Access to resources Recommend Favorite

Basic fibroblast growth factor and the complexity of tumour angiogenesis

By Rak J.   Kerbel R.S.  

Expert Opinion on Investigational Drugs, Vol. 7, Iss. 5, 1998-05 ,pp. : 797-801

Informa Healthcare

Access to resources Recommend Favorite

Fibroblast growth factor: potential for preventing radiation damage?

By  

Inpharma, Vol. 1, Iss. 1304, 2001-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Fibroblast Growth Factor Receptor Inhibitors

By  

Current Pharmaceutical Design, Vol. 19, Iss. 4, 2013-02 ,pp. : 687-701

Bentham Science Publishers

Access to resources Recommend Favorite

Novel glycidyl methacrylated dextran/gelatin nanoparticles loaded with basic fibroblast growth factor: formulation and characteristics

By Gu Chunhu   Zheng Renhong   Yang Zhifu   Wen Aidong   Wu Hong   Zhang Hui   Yi Dinghua  

Drug Development and Industrial Pharmacy, Vol. 35, Iss. 12, 2009-12 ,pp. : 1419-1429

Informa Healthcare

Access to resources Recommend Favorite